New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

Fein Talks CVS, Express Scripts and McKesson Transactions December 2, 2017
CVS Health Introduces New PBM Performance-based Pharmacy Network October 30, 2017
Express Scripts Blocks 48 Drugs August 10, 2018
JAMA Article Takes Look at Value-Based Drug Pricing June 6, 2018
Analysis Reinforces ’15 Study that Found Third of… August 13, 2018
Express Scripts, Walgreens Boots Partner on Biosimilars February 25, 2018
Report Focuses on Need for Value Assessment in Health Care February 26, 2018